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Introduction
Myogenic Diﬀerentiation 1 (MYOD1)
encodes a transcription factor that plays
an important role in myogenic determi-
nation into mature skeletal muscle [1].
The ﬁrst loss-of-function mutation of
MYOD1 in humans was described in
three siblings with perinatal lethal fetal
akinesia [2]. Here, we describe an individ-
ual with a loss-of-function mutation in
the MYOD1 gene and a congenital
myopathy with mild motor
developmental delay, ptosis and breath-
ing and feeding diﬃculties.
Case report
The patient, an 8-year-old girl, presented
a history of respiratory infections, hypoto-
nia, ptosis, motor delay and failure to
thrive, resulting in the placement of a gas-
trostomy by the age of 2 years. Bilevel
positive airway pressure during naps and
night-time sleep was started for severe
nocturnal hypercapnia. Muscular function
improved with age and remained stable
with mildly decreased endurance and bal-
ance. Pulmonary imaging showed bilateral
high diaphragmatic domes without pul-
monary hypoplasia (Appendix S1) and
diaphragmatic hypomobility on ﬂuo-
roscopy. Abdominal ultrasonography at
2 years revealed bilateral small kidney
(2 SD) without other anomalies. The
patient had a homozygous nonsense vari-
ant (c.697G>T; p.Glu233*) that segre-
gated with the phenotype (parents and
unaﬀected siblings are heterozygous carri-
ers). Informed consent was obtained.
Discussion
In the present case, we can observe that
the most severely aﬀected musculature
is the diaphragm. The lung hypoplasia
observed in the patient could be due to
the absence of mechanical forces origi-
nated by the proper functioning of the
diaphragm. Similar conclusions were
drawn from studies in a mouse model
of Myod1 and Dmd deﬁciency [3,4].
In 2016, the ﬁrst MYOD1 mutation in
humans was reported by Watson et al.
[2] in three siblings with perinatal lethal
fetal akinesia. Although the severity of
the phenotype is diﬀerent there are still
many similarities with the present indi-
vidual (clinical comparison in Table 1).
All patients present with triangular
facies, generalized muscle weakness, renal
anomalies and alterations in diaphrag-
matic function with respiratory insuﬃ-
ciency of variable degree. The previously
described pathogenic variant introduces a
stop codon in exon 1 within the basic
motif of the bHLH protein domain and
probably leads to nonsense-mediated
decay with absence of MYOD1 protein.
In contrast, the new stop codon in the
index patient is localized within 13 bp of
the exon 2/exon 3 junction
(Appendix S1), and is thus predicted not
to lead to nonsense-mediated decay [5].
Through this work, we thus contribute
to a better understanding of the MYOD1
myopathy phenotypic spectrum.
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Table 1 Clinical comparison of the four individuals with Myogenic Diﬀerentiation 1 homozygous mutations
Present individual
Watson et al. (2016)
III.1 III.2 III.4
Gender Female Male Male Female
Family history
Consanguinity + + + +
Pre-natal and perinatal history
Pre-natal anomalies – Cystic hygroma
polyhydramnios
Polyhydramnios Cystic hygroma
Birth At term 35 + 5 35 + 1 37
Growth Normal birth weight Low birth weight Low birth weight Low birth weight
Apgar ND 1-1 1-1 1-1
Neonatal death – + + +
Cranio facial symptoms
Triangular face + + + +
Downslanted palpebral ﬁssures + + ND ND
Ptosis + ND ND ND
Proptosis + ND ND ND
Mandible Prognathia Small chin Small chin Small chin
Palate High-arched Cleft Cleft Cleft
Dental malocclusion + NA NA NA
Respiratory symptoms
Respiratory insuﬃciency due to muscle
weakness
+ + + +
Diaphragm High domes Right-sided eventration Very high domes Extremely high domes
Pulmonary hypoplasia – + + +
Ventilatory support Nocturnal BiPAP Ventilator dependent
Musculoskeletal symptoms
Generalized muscle weakness + + + +
Fatigable weakness of swallowing
muscles
+ ND ND ND
Clinodactyly/digit overlapping + + + –
Cutaneous symptoms
Congenital, generalized hypertrichosis + ND ND ND
Genitourinary symptoms
Cryptorchidism NA Bilateral Unilateral NA
Renal anomaly Small kidneys
(–2 SD)
Bilateral renal pelvis
distension
Unilateral hydronephrosis Renal hypoplasia
BiPAP, bilevel positive airway pressure; NA, not applicable; ND, not done; +, present; –, absent.
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